As part of the JP Morgan week, Philipp will present the latest advances in our bacteria-based cancer therapy. This is a great opportunity to showcase our innovative approach and engage one-to-one with investors and biopharmaceutical executives.
Our COO, Philipp Busenhart, will present Recolony at the Biotech Showcase in San Francisco